Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare ITHospital ITElectronic Chart

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394084

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1394084

ePRO, E-patient Diaries and eCOA Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 299 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

In a world where technology continues to shape industries, the global healthcare sector is experiencing a remarkable transformation. With the rise in patients and mass casualties, healthcare professionals are actively exploring innovative instruments and pioneering treatment methods. As a result, the global ePRO, e-patient diaries, and eCOA market have witnessed unprecedented growth. These cutting-edge software solutions are revolutionizing healthcare communication and paving the way for a more connected and efficient healthcare ecosystem.

Connecting Through Innovation

ePRO, which stands for electronic patient-reported outcomes, and eCOA, electronic clinical outcome assessments, are the flagbearers of this transformation. Both technologies rely on electronic devices such as smartphones, tablets, and computers to collect and manage patient-related data. The surge in smartphone usage globally has fueled the demand for technologies like ePRO and eCOA, as they enable seamless communication and data collection in healthcare.

Meeting the Challenges

However, as with any technological advancement, there come challenges. In the realm of clinical communication and collaboration solutions, the generation of health data has raised security and privacy concerns. Global healthcare security policies mandate that patient data should be accessible only to authorized medical personnel. Yet, the rapid evolution of technology has exposed healthcare systems to potential fraudulent activities and cyber-attacks, posing inevitable risks that need to be addressed.

Market Projections

According to industry experts, the eCOA segment is anticipated to dominate the market from 2024 to 2031, making it the largest type of solution in the global ePRO, e-patient diaries, and eCOA market. Its attractiveness and dominance during this forecast period are projected to be unparalleled.

Diverse Applications

These technologies are versatile and cater to a wide range of end-users, including clinical trial sponsors, contract research organizations (CROs), hospitals, academic institutes, pharmaceutical companies, and medical device manufacturers. They can be seamlessly integrated into various healthcare modalities, including computers and mobile devices such as smartphones and tablets.

Global Reach

The impact of these advancements extends across the globe, with North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa all experiencing the transformative power of ePRO and eCOA technologies.

As the healthcare industry continues to evolve, these technological advancements promise to enhance real-time communication, improve patient outcomes, and drive innovation in the healthcare ecosystem. While security and privacy challenges persist, the benefits of these innovations are undeniable, and they are poised to reshape the future of healthcare.

The eCOA segment is expected to lead the global market by solution type, comprising:

  • 1. ePROs (Patient Reported Outcomes)
  • 2. ClinROs (Clinician Reported Outcomes)
  • 3. ObsROs (Observer Reported Outcomes)
  • 4. PerfOs (Performance Outcomes)
  • 5. E-Patient Diaries

The end users for these solutions include:

  • Clinical Trial Sponsors
  • Contract Research Organizations (CROs)
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Medical Device Manufacturers

These solutions are accessible through various modalities:

  • Computer
  • Mobile Devices (Smartphones and Tablets)

And they have a global presence in regions such as:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global EPRO, E-patient Diaries and eCOA Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Trend Analysis, 2018 - 2031

  • 3.1. Key Highlights
  • 3.2. Key Factors Impacting Solution Prices
  • 3.3. Prices By Solution

4. Global EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 4.1. Global EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 4.1.1.2. ePROs (Patient Reported Outcomes)
      • 4.1.1.3. ClinROs (Clinician Reported Outcomes)
      • 4.1.1.4. ObsROs (Observer Reported Outcomes)
      • 4.1.1.5. PerfOs (Performance Outcomes)
      • 4.1.1.6. E-Patient Diaries
    • 4.1.2. BPS Analysis/Market Attractiveness Analysis
  • 4.2. Global EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Computer
      • 4.2.1.2. Mobile Devices (Smartphones and Tablets)
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. Global EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Clinical Trial Sponsors
      • 4.3.1.2. Contract Research Organizations (CROs)
      • 4.3.1.3. Hospitals
      • 4.3.1.4. Academic Institutes
      • 4.3.1.5. Pharmaceutical Companies
      • 4.3.1.6. Medical Device Manufacturers
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. Global EPRO, E-patient Diaries and eCOA Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. North America EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 5.1. North America EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 5.1.1.2. ePROs (Patient Reported Outcomes)
      • 5.1.1.3. ClinROs (Clinician Reported Outcomes)
      • 5.1.1.4. ObsROs (Observer Reported Outcomes)
      • 5.1.1.5. PerfOs (Performance Outcomes)
      • 5.1.1.6. E-Patient Diaries
    • 5.1.2. BPS Analysis/Market Attractiveness Analysis
  • 5.2. North America EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Computer
      • 5.2.1.2. Mobile Devices (Smartphones and Tablets)
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. North America EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Clinical Trial Sponsors
      • 5.3.1.2. Contract Research Organizations (CROs)
      • 5.3.1.3. Hospitals
      • 5.3.1.4. Academic Institutes
      • 5.3.1.5. Pharmaceutical Companies
      • 5.3.1.6. Medical Device Manufacturers
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America EPRO, E-patient Diaries and eCOA Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. U.S. EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. U.S. EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. Canada EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. Canada EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. Canada EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 6.1. Europe EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 6.1.1.2. ePROs (Patient Reported Outcomes)
      • 6.1.1.3. ClinROs (Clinician Reported Outcomes)
      • 6.1.1.4. ObsROs (Observer Reported Outcomes)
      • 6.1.1.5. PerfOs (Performance Outcomes)
      • 6.1.1.6. E-Patient Diaries
    • 6.1.2. BPS Analysis/Market Attractiveness Analysis
  • 6.2. Europe EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Computer
      • 6.2.1.2. Mobile Devices (Smartphones and Tablets)
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Europe EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Clinical Trial Sponsors
      • 6.3.1.2. Contract Research Organizations (CROs)
      • 6.3.1.3. Hospitals
      • 6.3.1.4. Academic Institutes
      • 6.3.1.5. Pharmaceutical Companies
      • 6.3.1.6. Medical Device Manufacturers
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe EPRO, E-patient Diaries and eCOA Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. Germany EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. Germany EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. U.K. EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. U.K. EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. U.K. EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. France EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. France EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. France EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. Italy EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. Italy EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. Italy EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Turkey EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Turkey EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Turkey EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Russia EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Russia EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Russia EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.19. Rest of Europe EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 6.4.1.20. Rest of Europe EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.21. Rest of Europe EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 7.1. Asia Pacific EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 7.1.1.2. ePROs (Patient Reported Outcomes)
      • 7.1.1.3. ClinROs (Clinician Reported Outcomes)
      • 7.1.1.4. ObsROs (Observer Reported Outcomes)
      • 7.1.1.5. PerfOs (Performance Outcomes)
      • 7.1.1.6. E-Patient Diaries
    • 7.1.2. BPS Analysis/Market Attractiveness Analysis
  • 7.2. Asia Pacific EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Computer
      • 7.2.1.2. Mobile Devices (Smartphones and Tablets)
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Asia Pacific EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Clinical Trial Sponsors
      • 7.3.1.2. Contract Research Organizations (CROs)
      • 7.3.1.3. Hospitals
      • 7.3.1.4. Academic Institutes
      • 7.3.1.5. Pharmaceutical Companies
      • 7.3.1.6. Medical Device Manufacturers
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific EPRO, E-patient Diaries and eCOA Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. China EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. China EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. China EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Japan EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Japan EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Japan EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. South Korea EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. South Korea EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. South Korea EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. India EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. India EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. India EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.13. Southeast Asia EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.14. Southeast Asia EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.15. Southeast Asia EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.16. Rest of Asia Pacific EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 7.4.1.17. Rest of Asia Pacific EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.18. Rest of Asia Pacific EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 8.1. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
  • 8.2. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 8.2.1.2. ePROs (Patient Reported Outcomes)
      • 8.2.1.3. ClinROs (Clinician Reported Outcomes)
      • 8.2.1.4. ObsROs (Observer Reported Outcomes)
      • 8.2.1.5. PerfOs (Performance Outcomes)
      • 8.2.1.6. E-Patient Diaries
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Computer
      • 8.3.1.2. Mobile Devices (Smartphones and Tablets)
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Clinical Trial Sponsors
      • 8.4.1.2. Contract Research Organizations (CROs)
      • 8.4.1.3. Hospitals
      • 8.4.1.4. Academic Institutes
      • 8.4.1.5. Pharmaceutical Companies
      • 8.4.1.6. Medical Device Manufacturers
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Latin America EPRO, E-patient Diaries and eCOA Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. Brazil EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. Brazil EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. Mexico EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. Mexico EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. Mexico EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. Argentina EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. Argentina EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Argentina EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Rest of Latin America EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Rest of Latin America EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Rest of Latin America EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa EPRO, E-patient Diaries and eCOA Market Outlook, 2018 - 2031

  • 9.1. Middle East & Africa EPRO, E-patient Diaries and eCOA Market Outlook, by Solution, Value (US$ Bn), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. eCOA (Electronic Clinical Outcome Assessments)
      • 9.1.1.2. ePROs (Patient Reported Outcomes)
      • 9.1.1.3. ClinROs (Clinician Reported Outcomes)
      • 9.1.1.4. ObsROs (Observer Reported Outcomes)
      • 9.1.1.5. PerfOs (Performance Outcomes)
      • 9.1.1.6. E-Patient Diaries
    • 9.1.2. BPS Analysis/Market Attractiveness Analysis
  • 9.2. Middle East & Africa EPRO, E-patient Diaries and eCOA Market Outlook, by Modality Type, Value (US$ Bn), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Computer
      • 9.2.1.2. Mobile Devices (Smartphones and Tablets)
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis
  • 9.3. Middle East & Africa EPRO, E-patient Diaries and eCOA Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Clinical Trial Sponsors
      • 9.3.1.2. Contract Research Organizations (CROs)
      • 9.3.1.3. Hospitals
      • 9.3.1.4. Academic Institutes
      • 9.3.1.5. Pharmaceutical Companies
      • 9.3.1.6. Medical Device Manufacturers
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Mi ddle East & Africa EPRO, E-patient Diaries and eCOA Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 9.4.1.2. GCC EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 9.4.1.3. GCC EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 9.4.1.4. South Africa EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 9.4.1.5. South Africa EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 9.4.1.6. South Africa EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 9.4.1.7. Egypt EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 9.4.1.8. Egypt EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 9.4.1.9. Egypt EPRO, E-patient Diaries and eCOA Market Modality Type, Value (US$ Bn), 2018 - 2031
      • 9.4.1.10. Nigeria EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 9.4.1.11. Nigeria EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 9.4.1.12. Nigeria EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
      • 9.4.1.13. Rest of Middle East & Africa EPRO, E-patient Diaries and eCOA Market by Solution, Value (US$ Bn), 2018 - 2031
      • 9.4.1.14. Rest of Middle East & Africa EPRO, E-patient Diaries and eCOA Market by End User, Value (US$ Bn), 2018 - 2031
      • 9.4.1.15. Rest of Middle East & Africa EPRO, E-patient Diaries and eCOA Market by Modality Type, Value (US$ Bn), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Solution Providers vs End User Heatmap
  • 10.2. Company Market Share Analysis, 2023
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. ERT Clinical
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Service Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. ArisGlobal LLC
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Service Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. The Diary Pte. Ltd
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Service Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. ICON PLC
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Service Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. PAREXEL INTERNATIONAL CORPORATION
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Service Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Anju Software, Inc.
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Service Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Kayentis
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Service Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Bracket Global LLC
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Service Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Dassault Systemes SE
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Service Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. CRF Health
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Service Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. eClinical Solutions
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Service Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!